These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 34895332)

  • 1. Clinically aggressive pediatric spinal ependymoma with novel MYC amplification demonstrates molecular and histopathologic similarity to newly described MYCN-amplified spinal ependymomas.
    Shatara M; Schieffer KM; Klawinski D; Thomas DL; Pierson CR; Sribnick EA; Jones J; Rodriguez DP; Deeg C; Hamelberg E; LaHaye S; Miller KE; Fitch J; Kelly B; Leraas K; Pfau R; White P; Magrini V; Wilson RK; Mardis ER; Abdelbaki MS; Finlay JL; Boué DR; Cottrell CE; Ghasemi DR; Pajtler KW; Osorio DS
    Acta Neuropathol Commun; 2021 Dec; 9(1):192. PubMed ID: 34895332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MYCN amplification drives an aggressive form of spinal ependymoma.
    Ghasemi DR; Sill M; Okonechnikov K; Korshunov A; Yip S; Schutz PW; Scheie D; Kruse A; Harter PN; Kastelan M; Wagner M; Hartmann C; Benzel J; Maass KK; Khasraw M; Sträter R; Thomas C; Paulus W; Kratz CP; Witt H; Kawauchi D; Herold-Mende C; Sahm F; Brandner S; Kool M; Jones DTW; von Deimling A; Pfister SM; Reuss DE; Pajtler KW
    Acta Neuropathol; 2019 Dec; 138(6):1075-1089. PubMed ID: 31414211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High level MYCN amplification and distinct methylation signature define an aggressive subtype of spinal cord ependymoma.
    Raffeld M; Abdullaev Z; Pack SD; Xi L; Nagaraj S; Briceno N; Vera E; Pittaluga S; Lopes Abath Neto O; Quezado M; Aldape K; Armstrong TS; Gilbert MR
    Acta Neuropathol Commun; 2020 Jul; 8(1):101. PubMed ID: 32641156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MYCN immunohistochemistry as surrogate marker for MYCN-amplified spinal ependymomas.
    Mohan D; Nambirajan A; Malik R; Sharma A; Suri V; Kaur K; Doddamani R; Garg A; Gupta S; Mallick S; Sharma MC
    Hum Cell; 2024 May; 37(3):704-713. PubMed ID: 38411836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spinal Cord Ependymomas With MYCN Amplification Show Aggressive Clinical Behavior.
    Swanson AA; Raghunathan A; Jenkins RB; Messing-Jünger M; Pietsch T; Clarke MJ; Kaufmann TJ; Giannini C
    J Neuropathol Exp Neurol; 2019 Sep; 78(9):791-797. PubMed ID: 31373367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ependymomas of the spinal region in adults: Clinical and pathological features and MYCN expression levels in spinal ependymomas and myxopapillary ependymomas.
    Topel G; Dirilenoğlu F; Sevin İE; Kahraman A
    Ann Diagn Pathol; 2024 Jun; 70():152299. PubMed ID: 38555652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MYCN amplification in spinal ependymoma: A five-year retrospective study.
    Rao S; Sugur H; Konar S; Arivazhagan A; Santosh V
    Neuropathology; 2023 Dec; 43(6):457-462. PubMed ID: 37221449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric spinal ependymoma with chromothripsis of chromosome 6: a case report and review of the literature.
    Scott KR; Gener MA; Repnikova EA
    J Med Case Rep; 2024 Feb; 18(1):95. PubMed ID: 38351155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of DNA Methylation Classification in Diagnosing Ependymoma.
    Abe E; Suzuki M; Ichimura K; Arakawa A; Satomi K; Ogino I; Hara T; Iwamuro H; Ohara Y; Kondo A
    World Neurosurg; 2024 May; 185():e1019-e1029. PubMed ID: 38479644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical outcomes in spinal cord ependymomas and the importance of extent of resection in children and young adults.
    Safaee M; Oh MC; Mummaneni PV; Weinstein PR; Ames CP; Chou D; Berger MS; Parsa AT; Gupta N
    J Neurosurg Pediatr; 2014 Apr; 13(4):393-9. PubMed ID: 24506340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intradural Extramedullary Nonconus Nonfilum Spinal Ependymomas: Report of a Rare Variant and Newer Insights into Their Histogenesis with Proposal of a Classification Scheme and a Management Algorithm Based on a Review of Literature.
    Das KK; Attri G; Singh S; Bhaisora KS; Verma P; Jaiswal S; Jaiswal A; Behari S
    World Neurosurg; 2020 Feb; 134():323-336. PubMed ID: 31682991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal holocord recurrence of a pregnancy-related, low-grade spinal ependymoma: case report and review of an unusual clinical phenomenon.
    Thakar S; Sivaraju L; Ghosal N; Aryan S; Hegde AS
    Spinal Cord Ser Cases; 2020 Oct; 6(1):93. PubMed ID: 33009374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostics of pediatric supratentorial RELA ependymomas: integration of information from histopathology, genetics, DNA methylation and imaging.
    Pagès M; Pajtler KW; Puget S; Castel D; Boddaert N; Tauziède-Espariat A; Picot S; Debily MA; Kool M; Capper D; Sainte-Rose C; Chrétien F; Pfister SM; Pietsch T; Grill J; Varlet P; Andreiuolo F
    Brain Pathol; 2019 May; 29(3):325-335. PubMed ID: 30325077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intradural extramedullary spinal ependymoma: a benign pathology?
    Robles SG; Saldaña C; Boto GR; Martinez A; Zamarron AP; Jorquera M; Mata P
    Spine (Phila Pa 1976); 2005 May; 30(9):E251-4. PubMed ID: 15864145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphology-based molecular classification of spinal cord ependymomas using deep neural networks.
    Schumann Y; Dottermusch M; Schweizer L; Krech M; Lempertz T; Schüller U; Neumann P; Neumann JE
    Brain Pathol; 2024 Sep; 34(5):e13239. PubMed ID: 38205683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thoracic exophytic ependymoma masquerading as a benign extra-axial tumor.
    Chung CY; Koffie RM; Dewitt JC; Aronson JP
    J Clin Neurosci; 2016 Nov; 33():221-225. PubMed ID: 27578528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifocal intradural extramedullary ependymoma,
    Shields LBE; Sun DA; Highfield HA; LaRocca RV; Spalding AC; Sinicrope KD; Zhang YP; Shields CB
    J Neurosurg Case Lessons; 2022 May; 3(22):CASE22141. PubMed ID: 35734608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of pediatric Grade II spinal ependymomas: a population-based study.
    Lin Y; Jea A; Melkonian SC; Lam S
    J Neurosurg Pediatr; 2015 Mar; 15(3):243-9. PubMed ID: 25525932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinal cord ependymomas and myxopapillary ependymomas in the first 2 decades of life: a clinicopathological and immunohistochemical characterization of 19 cases.
    Stephen JH; Sievert AJ; Madsen PJ; Judkins AR; Resnick AC; Storm PB; Rushing EJ; Santi M
    J Neurosurg Pediatr; 2012 Jun; 9(6):646-53. PubMed ID: 22656257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation-based classification of ependymomas in adulthood: implications for diagnosis and treatment.
    Witt H; Gramatzki D; Hentschel B; Pajtler KW; Felsberg J; Schackert G; Löffler M; Capper D; Sahm F; Sill M; von Deimling A; Kool M; Herrlinger U; Westphal M; Pietsch T; Reifenberger G; Pfister SM; Tonn JC; Weller M;
    Neuro Oncol; 2018 Nov; 20(12):1616-1624. PubMed ID: 30053291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.